Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability Centers (GCCs) have emerged as a transformative solution. Our latest whitepaper, "Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence," explores how GCCs—especially those based in India—are reshaping how the industry manages scientific…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
Emerging Technologies: Healthcare Communication Friend or Foe?
Embracing emerging technologies and innovations is not just an option but a necessity for biopharma...
The Quest for Omnichannel: Is Medical Affairs Ready?
Commercial and Medical Affairs must partner with each other to achieve the real benefits of...
Breaking Barriers: Exploring the Power of AI and NLP in Scientific Communication
Learn how medical publication professionals and medical affairs teams can embrace AI and NLP tools...
Which Regulatory Requirements Are Applicable to “Legacy” Devices?
Understanding the requirements for your medical device is vital in today’s market. But are these...
HEOR in 2022: The Importance of Data Visualization, RWD, and Interactive Formats
Effectively communicating data in the pharmaceutical and medical community is vital to payer engagement. Learn...
Simple Considerations before Determining S&P Objectives for Medical Devices
With all the things to consider with Medical Device Regulations, it's important to identify the...